Press-release for stocks for fate

Prices are updated after-hours

| 94.15% | O: 1.06% H: 1.44% C: 0.0%
FATE | News | $4.3 -5.29% -5.58% 2M

| -78.54% | O: -1.65% H: 3.2% C: -1.32%
biopharma aml meeting

Fate Therapeutics to Present Clinical and Preclinical Data for iPSC Product Platform at the 2022 ASH Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
FATE | News | $4.3 -5.29% -5.58% 2M

| -78.54% | O: -1.65% H: 3.2% C: -1.32%
preclinical meeting therapeutics platform

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.